According to the pricing breakdown provided by the firm, the three-dose needle-free COVID-19 vaccine from zydus Cadila would cost the Centre Rs 1,128. On November 8, the pharma company said that it had acquired a purchase order from the Union government to deliver one crore doses of ZyCoV-D at a cost of Rs 265 per dosage, excluding jet applicator and GST.
“Zydus Cadila has obtained an order from the Government of India to provide one crore doses of ZyCoV-D, the world’s first Plasmid DNA Vaccine, for Rs 265 per dosage and the needle-free applicator at Rs 93 per dose, excluding GST,” the pharma business said in a regulatory filing.
According to the price break up, a single dose of the vaccine will be made available to the Centre at Rs 376 which includes the cost of the jet applicator and GST, taking the price of 3-dose jab to Rs 1,128.
The vaccine maker said that the pricing has been decided in consultation with the Centre.
The vaccine will be administered using a needle-free applicator, called PharmaJet, instead of traditional syringes.
The PharmaJet is a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said.
The firm said that ZyCov-D has shown good stability at temperatures of around 25 degrees for at least three months.
ZyCoV-D is the first vaccine cleared by India’s drug regulator for inoculation of those aged 12 years and above.
The three doses of ZyCoV-D, are to be administered 28 days apart. The vaccine was given emergency use authorization (EUA) by the Indian drug regulator on August 20.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…